Treatment of Vascular Malformations in Newborns and Infants

  • Géza Tasnádi


There is little information on the physiological features of the circulation in the newborn and infant. The first haemodynamic change which may induce the development of latent vascular malformations appears when the umbilical cord is cut. Stopping the maternal-neonatal contact also produces important hormonal and metabolic changes. All these effects appear complex in case of already avoidable vascular malformations. At the same time, the vascular malformations have a great influence on the systemic circulation and on the development of the extremity, particularly in this age group. We can prevent the serious sequelae of vascular defects by beginning treatment at the appropriate time — even in neonates and infants — and providing well-planned treatment. Indications for therapy and treatments according to the type of vascular malformation are described in this chapter.


Inferior Vena Cava Vascular Malformation Venous Malformation Chylous Ascites Chyle Leak 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kiss F, Szentágotai J (1984) Anatomischer Atlas des Menchlichen körpers. Ed Medicina, BudapestGoogle Scholar
  2. 2.
    Tasnádi G (1977) Clinical examinations of venous dysplasias of infant and childhood. Dissertation, University of BudapestGoogle Scholar
  3. 3.
    Wang Z (1998) Congenital defects of the inferior vena cava causing Budd-Chiari syndrome. In: Selected sc. papers of Zhong Gao Wang. Int Academic Publishers, Beijing, pp 360–367Google Scholar
  4. 4.
    Wong WH, Pyk J (1976) Blood flow and venous distensibilities in the upper and lower extremity of newborns and infants. Acta Paed Uppsala 65:571–576CrossRefGoogle Scholar
  5. 5.
    Belov S (1990) Hemodynamic pathogenesis of vascular bone syndromes in congenital vascular defects. Int Angiol 9:155–162PubMedGoogle Scholar
  6. 6.
    Mattassi R, Belov S, Loose DA, Vaghi M (2003) Malformazioni vascolari ed emangiomi. Springer-Verlag Italia, MilanoGoogle Scholar
  7. 7.
    Soltész L (1965) Contribution of clinical and experimental studies of the hypertrophy of the extremities in congenital a-v fistulas. Proceedings of the 7th Congress of the International Cardiovascular Society, Philadelphia. J Cardiovasc Surg (Suppl 6):260–262Google Scholar
  8. 8.
    Tasnádi G (1989) Parkes-Weber Syndrome on the lower extremity and retroperitoneal angiolipomatosis. In: Belov S, Loose DA, Weber J (eds) Vascular malformations. Periodica Angiologica 16. Einhorn-Presse Verlag, Reinbek, pp 226–229Google Scholar
  9. 9.
    Tasnádi G (1989) Phlebangiomas and their treatment. In: Belov S, Loose DA, Weber J (eds) Vascular malformations. Periodica Angiologica 16, Einhorn-Presse Verlag, Reinbek, pp 183–187Google Scholar
  10. 10.
    Tasnádi G (1992) Clinical investigations in epidemiology of congenital vascular defects. In: Balas P (ed) Progress in angiology. Edizioni Minerva Medica, Torino, pp 391–394Google Scholar
  11. 11.
    Tasnádi G, Mattassi R (1998) Chyledema of a limb and chylothorax treated successfully with a Denver shunt. Lymphology 31:381–385Google Scholar
  12. 12.
    Acsady GY, Nemes A (2005) Az érbetegségek Klinikai és mütéttani atlasza. Ed. Medicina BudapestGoogle Scholar
  13. 13.
    Sarkar R (1991) Arterial aneurysms in children. Clinicopathologic classification. J Vasc Surg 13:147Google Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Géza Tasnádi
    • 1
  1. 1.BudapestHungary

Personalised recommendations